Avatar

TGCT Overview: Considering Surgical Options and Pexidartinib

By William Eward
1,315 views
March 10, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

19:05
Deciphera

Patient Case Discussion on a Treatment Approach for Advanced Gastroi…

Feat. M. Agulnik

Featured Video

09:52
Deciphera

Treatment Approach for Advanced Gastrointestinal Stromal Tumor (GIST…

Feat. K. Polson

Related Content

AUTOPLAY
22:07

2024 Update in Sarcomas

Total Health

D. Portnoy

525 views
11:54

ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients…

2024 ESMO Annual Meeting Insights Hub

R. Van den Begin

261 views
22:27

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

526 views
25:02

Sarcoma 101: Multidisciplinary Approach, Therapies, and Future Direc…

Total Health

B. Wilky

218 views
16:37

ASCO® 2024 Highlights in Sarcomas

2024 ASCO® Annual Meeting Insights Hub

R. Jones

192 views
25:23

NCCN Clinical Practice Guidelines for Treating GIST

Andrea Napolitano

390 views
19:40

Gastrointestinal Stromal Tumors (GIST) and Resistance Mutations

Warren Chow

341 views
18:08

ASCO® 2024 Highlights: Advances in GIST Tumors and Soft Tissue Sarco…

2024 ASCO® Annual Meeting Insights Hub

A. Hussein

142 views
18:46

Systemic Therapies for Uterine Leiomyosarcoma

OncoAlert

I. Ray-Coquard

332 views
21:12

What Is New in Treatment of Soft Tissue and Bone Sarcoma

ISCO - International School of Clinical Oncology

S. Stacchiotti

217 views
22:21

Divide and Conquer Sarcomas Through Precision Oncology

Miami Cancer Institute Precision Oncology Symposium

N. Somaiah

105 views
15:45

Multidisciplinary Management of Advanced Soft Tissue Sarcoma

i3 Health

S. Patel, B. Ruben, K. Polson

247 views
10:55

ESMO 2023 Insights: "Novel Combinations in Sarcomas"

Insights from 2023 ESMO Annual Meeting

R. Jones

245 views
24:45

Precision Oncology in the Diagnosis and Management of Sarcoma

University of Miami Sylvester Comprehensive Cancer Center

S. Bialick

68 views
10:48

INSIGHT: A Phase 3 Study of Ripretinib vs. Sunitinib in Pts With Adv…

Insights from 2024 ASCO® GI Annual Meeting

J. Zalcberg

186 views
07:00

ctDNA Analysis From INTRIGUE Study: Updated OS & Safety With Ripreti…

Insights from 2024 ESMO Sarcoma and Rare Cancers Congress

J. Blay

192 views
17:20

New

ESMO 2024 Summary: Highlights of Important Trials in Sarcoma

2024 ESMO Annual Meeting Insights Hub

R. Jones

56 views
18:44

2023 West Oncology Conference: Soft Tissue Sarcoma Updates

2023 West Oncology Conference

B. Van Tine

514 views
11:03

Final Analyses From INTRIGUE: OS & Long-Term Safety With Ripretinib …

Insights from 2024 ASCO® GI Annual Meeting

J. Zalcberg

178 views
04:54

ASCO® 2024 Insights: "PROs of the MEDISARC Study (AIO-STS-0415) - Du…

2024 ASCO® Annual Meeting Insights Hub

V. Grünwald

72 views